BIZTRAC BETA
Technical testing and analysis

MEDDOC AS

Org. no. 881153262 Limited company (AS) Lillestrøm Incorporated 1999 Active
Ownership graph ↗
Revenue 2024 NOK 12.4m
Operating profit NOK 473,000
Equity NOK 876,000
Incorporated 1999
Employees 13
Share capital NOK 100,000

MEDDOC AS is registered as a limited company in Lillestrøm, Akershus with organisation number 881153262. The business is classified under technical testing and analysis (NACE 71.200). The company was incorporated in 1999 and has 13 registered employees. Registered share capital is NOK 100,000, divided into 100 shares. The company's stated purpose is: “Planlegging, gjennomføring og analyse av epidenualogisk og kontrollerte studier. Planlegging, gjennomføring og analyse av epidenualogisk og kontrollerte studier.idere annen relatert virksomhet knyttet til primærnæringen.”. The most recent filed accounts, for the 2024 financial year, show NOK 12.4m in revenue and NOK 473,000 in operating profit.

Key figures · 2024

Revenue
NOK 12.4m
Operating profit
NOK 473,000
Equity
NOK 876,000
Est. value
NOK 2.8m

Financial health · 2024

Liquidity
1.28
Satisfactory
Current assets ÷ current liabilities
Profitability
Not available
Return on total assets
Solidity
21.4%
Good
Equity as a share of total capital

Who owns MEDDOC AS?

STIG EINRIDE LARSEN
MEDDOC AS
NOK 12.4m rev. · NOK 473,000 profit

MEDDOC AS has 4 registered shareholders:

All shareholders and roles →

Frequently asked questions about MEDDOC AS

Who owns MEDDOC AS?

STIG EINRIDE LARSEN is the largest registered owner, with 60.0%.

What is the revenue of MEDDOC AS?

MEDDOC AS had revenue of NOK 12.4m in 2024.

Who is the general manager of MEDDOC AS?

Stig Einride Larsen is registered as general manager of MEDDOC AS.

Where is MEDDOC AS based?

MEDDOC AS has its business address in Skjetten.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.